Prime Medicine
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Prime Medicine and other ETFs, options, and stocks.About PRME
Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R.
CEOAllan Jacob Reine
CEOAllan Jacob Reine
Employees214
Employees214
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2019
Founded2019
Employees214
Employees214
PRME Key Statistics
Market cap667.89M
Market cap667.89M
Price-Earnings ratio-2.61
Price-Earnings ratio-2.61
Dividend yield—
Dividend yield—
Average volume3.40M
Average volume3.40M
High today$3.94
High today$3.94
Low today$3.69
Low today$3.69
Open price$3.88
Open price$3.88
Volume1.69M
Volume1.69M
52 Week high$6.94
52 Week high$6.94
52 Week low$1.11
52 Week low$1.11
Stock Snapshot
With a market cap of 667.89M, Prime Medicine(PRME) trades at $3.70. The stock has a price-to-earnings ratio of -2.61.
As of 2025-12-05, Prime Medicine(PRME) stock has fluctuated between $3.69 and $3.94. The current price stands at $3.70, placing the stock +0.3% above today's low and -6.1% off the high.
Prime Medicine(PRME) shares are trading with a volume of 1.69M, against a daily average of 3.4M.
In the last year, Prime Medicine(PRME) shares hit a 52-week high of $6.94 and a 52-week low of $1.11.
In the last year, Prime Medicine(PRME) shares hit a 52-week high of $6.94 and a 52-week low of $1.11.
Analyst ratings
64%
of 11 ratingsBuy
63.6%
Hold
36.4%
Sell
0%
People also own
Based on the portfolios of people who own PRME. This list is generated using Robinhood data, and it’s not a recommendation.